Boston Scientific Corp. last week announced that it has closed on its acquisition of Irvine-based medical device maker ...

BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Boston Scientific announced the acquisition in January, but the review dragged on after the Federal Trade Commission ...

Boston Scientific’s BSX growth in the third quarter of 2024 was backed by its successful expansion of operations across ...

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...

Axonics (NASDAQ:AXNX) quickly edged higher by 0.8% after a Nasdaq delisting notice for its planned sale to Boston Scientific ...

On Thursday, Axonics Inc (AXNX) stock saw a modest uptick, ending the day at $70.98 which represents a slight increase of $0.53 or 0.75% from the prior close of $70.45. The stock opened at $70.5 and ...

Axonics Modulation Technologies ( (AXNX) ) has released its Q3 earnings. Here is a breakdown of the information Axonics Modulation Technologies ...

How To Join The OC500 - Orange County Business Journal's Editor-in-Chief Peter Brennan provides information on how to be ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an ...